NA Exosome Research Products Market - Industry Trends And Forecast To 2030

Description

List of Tables

North America exosome research products market is projected to register a substantial CAGR of 35.5% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

North America Exosome Research Products Market, By Product (Instruments and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030

Market Drivers

Growing prevalence of cancer, chronic inflammation, autoimmune disease, Lyme disease, and other chronic degenerative diseases

Increasing investments in pharmaceutical R&D and life sciences research

Market Players:

The key market players in North America colorectal cancer diagnostics market are listed below:

Hologic Inc.

Luminex Corporation

Thermo Fisher Scientific

Agilent Technologies, Inc.

RoosterBio, Inc.

Cell Guidance Systems LLC

QIAGEN

FUJIFILM Irvine Scientific( a subsidiary of FUJIFILM Holdings Corporation)

CUSABIO TECHNOLOGY LLC

NEXOSOME-ONCOLOGY

Norgen Biotek Corp.

Miltenyi Biotec

Aethlon Medical, Inc.,

System Biosciences, LLC.

AMSBIO, ExoDx (Acquired By Bio-Techne)

BioVision Inc. (Acquired By Abcam plc)

Creative Bioarray

NanoSomiX

Novus Biologicals

Beckman Coulter, Inc.

Hitachi, Ltd.

ProteoGenex

Audubon Bioscience

Novus Biologicals

Beckman Coulter, Inc.

Hitachi, Ltd

ProteoGenex

Audubon Bioscience

1 INTRODUCTION 53

1.1 OBJECTIVES OF THE STUDY 53
1.2 MARKET DEFINITION 53
1.3 OVERVIEW OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET 53
1.4 LIMITATIONS 55
1.5 MARKETS COVERED 55

2 MARKET SEGMENTATION 58

2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 PRODUCT LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 69
2.11 VENDOR SHARE ANALYSIS 70
2.12 SECONDARY SOURCES 71
2.13 ASSUMPTIONS 71

3 EXECUTIVE SUMMARY 72

4 PREMIUM INSIGHTS 74

4.1 PESTEL ANALYSIS 75
4.2 PORTER'S FIVE FORCES MODEL 76
4.3 SUPPLY CHAIN ANALYSIS 77
4.4 VALUE CHAIN ANALYSIS 78
4.5 BUSINESS STRATEGY EXCELLENCE 79
4.6 CASE STUDIES 80
4.7 STRENGTH OF PRODUCT PORTFOLIO 82
4.8 TECHNOLOGICAL TRENDS 84
4.9 PRICING ANALYSIS 85

5 INDUSTRY INSIGHTS 86

6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 87

7 MARKET OVERVIEW 89

7.1 DRIVERS 91
- 7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 91
- 7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 91
- 7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 92
7.2 RESTRAINTS 93
- 7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 93
- 7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 93
7.3 OPPORTUNITIES 94
- 7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 94
- 7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 94
- 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 95
7.4 CHALLENGES 96
- 7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 96
- 7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 96

8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 97

8.1 OVERVIEW 98
8.2 CONSUMABLES 101
- 8.2.1 KITS AND REAGENTS 102
  - 8.2.1.1 EXOSOME BIOMARKER KITS 103
  - 8.2.1.2 EXOSOME ISOLATION KITS 103
  - 8.2.1.3 EXOSOME PURIFICATION KITS 103
  - 8.2.1.4 EXOSOME QUANTITATIVE KITS 103
  - 8.2.1.5 EXOSOME DETECTION KITS 103
  - 8.2.1.6 OTHERS 103
- 8.2.2 EXOSOME STANDARDS 103
- 8.2.3 EXOSOME ANTIBODIES 103
- 8.2.4 CELL LINES 103
- 8.2.5 IMMUNOPLATES 104
- 8.2.6 IMMUNOBEADS 104
- 8.2.7 BIOFLUIDS 104
- 8.2.8 OTHERS 104
8.3 INSTRUMENTS 104
- 8.3.1 BENCHTOP 105
- 8.3.2 STANDALONE 105

9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 106

9.1 OVERVIEW 107
9.2 CANCER 110
- 9.2.1 LUNG CANCER 111
- 9.2.2 BREAST CANCER 111
- 9.2.3 COLORECTAL CANCER 111
- 9.2.4 PROSTATE CANCER 112
- 9.2.5 OTHER CANCER 112
9.3 NON-CANCER 112
- 9.3.1 CARDIOVASCULAR DISEASE 113
- 9.3.2 NEURODEGENERATIVE DISEASE 113
- 9.3.3 INFECTIOUS DISEASE 113
- 9.3.4 OTHERS 113

10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 114

10.1 OVERVIEW 115
10.2 THERAPEUTICS 118
10.3 CONSUMABLES 119
10.4 INSTRUMENTS 119
10.5 DIAGNOSIS 119
10.6 CONSUMABLES 120
10.7 INSTRUMENTS 120

11 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 121

11.1 OVERVIEW 122
11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 125
11.3 CONSUMABLES 126
11.4 INSTRUMENTS 126
11.5 RESEARCH CENTRES 126
11.6 CONSUMABLES 127
11.7 INSTRUMENTS 127
11.8 ACADEMIC INSTITUTES 127
11.9 CONSUMABLES 128
11.10 INSTRUMENTS 128
11.11 CLINICAL TESTING LABORATORY 128
11.12 CONSUMABLES 129
11.13 INSTRUMENTS 129
11.14 HOSPITALS 130
11.15 CONSUMABLES 131
11.16 INSTRUMENTS 131
11.17 OTHERS 131

12 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 132

12.1 OVERVIEW 133
12.2 THIRD PARTY DISTRIBUTORS 136
12.3 DIRECT SALES 136
12.4 ONLINE 137

13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 138

13.1 NORTH AMERICA 139
- 13.1.1 U.S. 149
- 13.1.2 CANADA 155
- 13.1.3 MEXICO 161

14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 167

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 167

15 SWOT ANALYSIS 168

16 COMPANY PROFILE 169

16.1 THERMO FISHER SCIENTIFIC INC. 169
- 16.1.1 COMPANY SNAPSHOT 169
- 16.1.2 REVENUE ANALYSIS 169
- 16.1.3 COMPANY SHARE ANALYSIS 170
- 16.1.4 PRODUCT PORTFOLIO 170
- 16.1.5 RECENT DEVELOPMENT 171
16.2 EXODX (ACQUIRED BY BIO-TECHNE) 172
- 16.2.1 COMPANY SNAPSHOT 172
- 16.2.2 REVENUE ANALYSIS 172
- 16.2.3 COMPANY SHARE ANALYSIS 173
- 16.2.4 PRODUCT PORTFOLIO 173
- 16.2.5 RECENT DEVELOPMENT 173
16.3 MILTENYI BIOTEC 174
- 16.3.1 COMPANY SNAPSHOT 174
- 16.3.2 COMPANY SHARE ANALYSIS 174
- 16.3.3 PRODUCT PORTFOLIO 175
- 16.3.4 RECENT DEVELOPMENTS 175
16.4 LUMINEX CORPORATION 176
- 16.4.1 COMPANY SNAPSHOT 176
- 16.4.2 PRODUCT PORTFOLIO 176
- 16.4.3 RECENT DEVELOPMENT 176
16.5 HOLOGIC, INC. 177
- 16.5.1 COMPANY SNAPSHOT 177
- 16.5.2 REVENUE ANALYSIS 177
- 16.5.3 COMPANY SHARE ANALYSIS 178
- 16.5.4 PRODUCT PORTFOLIO 178
- 16.5.5 RECENT DEVELOPMENTS 178
16.6 AETHLON MEDICAL, INC. (2022) 179
- 16.6.1 COMPANY SNAPSHOT 179
- 16.6.2 PRODUCT PORTFOLIO 180
- 16.6.3 RECENT DEVELOPMENTS 180
16.7 AGILENT TECHNOLOGIES, INC. 181
- 16.7.1 COMPANY SNAPSHOT 181
- 16.7.2 REVENUE ANALYSIS 181
- 16.7.3 PRODUCT PORTFOLIO 182
- 16.7.4 RECENT DEVELOPMENT 182
16.8 AMSBI0 183
- 16.8.1 COMPANY SNAPSHOT 183
- 16.8.2 PRODUCT PORTFOLIO 183
- 16.8.3 RECENT DEVELOPMENT 183
16.9 AUDUBON BIOSCIENCE. 184
- 16.9.1 COMPANY SNAPSHOT 184
- 16.9.2 PRODUCT PORTFOLIO 184
- 16.9.3 RECENT DEVELOPMENT 184
16.10 BECKMAN COULTER, INC 185
- 16.10.1 COMPANY SNAPSHOT 185
- 16.10.2 PRODUCT PORTFOLIO 185
- 16.10.3 RECENT DEVELOPMENT 185
16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 186
- 16.11.1 COMPANY SNAPSHOT 186
- 16.11.2 REVENUE ANALYSIS 186
- 16.11.3 COMPANY SHARE ANALYSIS 187
- 16.11.4 PRODUCT PORTFOLIO 187
- 16.11.5 RECENT DEVELOPMENT 187
16.12 CELL GUIDANCE SYSTEMS LLC 188
- 16.12.1 COMPANY SNAPSHOT 188
- 16.12.2 PRODUCT PORTFOLIO 188
- 16.12.3 RECENT DEVELOPMENTS 188
16.13 CREATIVE BIOARRAY 189
- 16.13.1 COMPANY SNAPSHOT 189
- 16.13.2 PRODUCT PORTFOLIO 189
- 16.13.3 RECENT DEVELOPMENT 189
16.14 CUSABIO TECHNOLOGY LLC 190
- 16.14.1 COMPANY SNAPSHOT 190
- 16.14.2 PRODUCT PORTFOLIO 190
- 16.14.3 RECENT DEVELOPMENTS 190
16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 191
- 16.15.1 COMPANY SNAPSHOT 191
- 16.15.2 REVENUE ANALYSIS 191
- 16.15.3 PRODUCT PORTFOLIO 192
- 16.15.4 RECENT DEVELOPMENT 192
16.16 HBMLS (ACQUIRED BY LONZA) 193
- 16.16.1 COMPANY SNAPSHOT 193
- 16.16.2 REVENUE ANALYSIS 193
- 16.16.3 PRODUCT PORTFOLIO 194
- 16.16.4 RECENT DEVELOPMENT 194
16.17 HITACHI, LTD. 195
- 16.17.1 COMPANY SNAPSHOT 195
- 16.17.2 REVENUE ANALYSIS 195
- 16.17.3 PRODUCT PORTFOLIO 196
- 16.17.4 RECENT DEVELOPMENT 196
16.18 INOVIQ 197
- 16.18.1 COMPANY SNAPSHOT 197
- 16.18.2 REVENUE ANALYSIS 197
- 16.18.3 PRODUCT PORTFOLIO 198
- 16.18.4 RECENT DEVELOPMENT 198
16.19 JSR MICRO NV 199
- 16.19.1 COMPANY SNAPSHOT 199
- 16.19.2 PRODUCT PORTFOLIO 199
- 16.19.3 RECENT DEVELOPMENT 199
16.20 MICROGENTAS 200
- 16.20.1 COMPANY SNAPSHOT 200
- 16.20.2 PRODUCT PORTFOLIO 200
- 16.20.3 RECENT DEVELOPMENTS 200
16.21 NANOSOMIX 201
- 16.21.1 COMPANY SNAPSHOT 201
- 16.21.2 PRODUCT PORTFOLIO 201
- 16.21.3 RECENT DEVELOPMENT 201
16.22 NEXOSOME-ONCOLOGY 202
- 16.22.1 COMPANY SNAPSHOT 202
- 16.22.2 PRODUCT PORTFOLIO 202
- 16.22.3 RECENT DEVELOPMENTS 202
16.23 NORGEN BIOTEK CORP. 203
- 16.23.1 COMPANY SNAPSHOT 203
- 16.23.2 PRODUCT PORTFOLIO 203
- 16.23.3 RECENT DEVELOPMENTS 203
16.24 NOVUS BIOLOGICALS 204
- 16.24.1 COMPANY SNAPSHOT 204
- 16.24.2 PRODUCT PORTFOLIO 204
- 16.24.3 RECENT DEVELOPMENT 205
16.25 PROTEOGENEX 206
- 16.25.1 COMPANY SNAPSHOT 206
- 16.25.2 PRODUCT PORTFOLIO 206
- 16.25.3 RECENT DEVELOPMENT 206
16.26 QIAGEN 207
- 16.26.1 COMPANY SNAPSHOT 207
- 16.26.2 REVENUE ANALYSIS 207
- 16.26.3 PRODUCT PORTFOLIO 208
- 16.26.4 RECENT DEVELOPMENT 208
16.27 ROOSTERBIO, INC. 209
- 16.27.1 COMPANY SNAPSHOT 209
- 16.27.2 PRODUCT PORTFOLIO 209
- 16.27.3 RECENT DEVELOPMENTS 210
16.28 SYSTEM BIOSCIENCES, LLC. 211
- 16.28.1 COMPANY SNAPSHOT 211
- 16.28.2 PRODUCT PORTFOLIO 211
- 16.28.3 RECENT DEVELOPMENT 211

17 QUESTIONNAIRE 212

LIST OF TABLES

TABLE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS 51
TABLE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND) 66
TABLE 3 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 67
TABLE 4 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 68
TABLE 5 NORTH AMERICA KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 68
TABLE 6 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 71
TABLE 7 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 71
TABLE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 75
TABLE 9 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
TABLE 10 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 77
TABLE 11 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 78
TABLE 12 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 79
TABLE 13 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 83
TABLE 14 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 84
TABLE 15 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 84
TABLE 16 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 85
TABLE 17 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 86
TABLE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 90
TABLE 19 NORTH AMERICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 91
TABLE 20 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 91
TABLE 21 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
TABLE 22 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 93
TABLE 23 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 94
TABLE 24 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 94
TABLE 25 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 95
TABLE 26 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 95
TABLE 27 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
TABLE 28 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 96
TABLE 29 NORTH AMERICA OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
TABLE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 101
TABLE 31 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 102
TABLE 32 NORTH AMERICA DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 33 NORTH AMERICA ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 103
TABLE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 109
TABLE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 109
TABLE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 109
TABLE 37 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 110
TABLE 38 NORTH AMERICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 110
TABLE 39 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 111
TABLE 40 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 111
TABLE 41 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 111
TABLE 42 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 112
TABLE 43 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
TABLE 44 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
TABLE 45 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 112
TABLE 46 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 113
TABLE 47 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 113
TABLE 48 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 113
TABLE 49 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 114
TABLE 50 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 114
TABLE 51 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 114
TABLE 52 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 114
TABLE 53 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 115
TABLE 54 U.S. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 115
TABLE 55 U.S. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 116
TABLE 56 U.S. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 116
TABLE 57 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 116
TABLE 58 U.S. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 117
TABLE 59 U.S. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 117
TABLE 60 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 117
TABLE 61 U.S. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
TABLE 62 U.S. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
TABLE 63 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 64 U.S. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 119
TABLE 65 U.S. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 119
TABLE 66 U.S. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 119
TABLE 67 U.S. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 119
TABLE 68 U.S. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 120
TABLE 69 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 120
TABLE 70 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
TABLE 71 CANADA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 121
TABLE 72 CANADA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 122
TABLE 73 CANADA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 122
TABLE 74 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 122
TABLE 75 CANADA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 123
TABLE 76 CANADA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 123
TABLE 77 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
TABLE 78 CANADA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 124
TABLE 79 CANADA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 124
TABLE 80 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 124
TABLE 81 CANADA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 82 CANADA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 83 CANADA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 84 CANADA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 125
TABLE 85 CANADA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 126
TABLE 86 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 126
TABLE 87 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 127
TABLE 88 MEXICO CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 127
TABLE 89 MEXICO KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 128
TABLE 90 MEXICO INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 128
TABLE 91 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 128
TABLE 92 MEXICO CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 129
TABLE 93 MEXICO NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 129
TABLE 94 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
TABLE 95 MEXICO THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 130
TABLE 96 MEXICO DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 130
TABLE 97 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 98 MEXICO PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 99 MEXICO RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 100 MEXICO ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 101 MEXICO CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 131
TABLE 102 MEXICO HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
TABLE 103 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 132

LIST OF FIGURES

FIGURE 1 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 23
FIGURE 2 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION 26
FIGURE 3 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS 27
FIGURE 4 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS 28
FIGURE 5 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS 28
FIGURE 6 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS 31
FIGURE 7 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID 32
FIGURE 8 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID 34
FIGURE 9 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS 35
FIGURE 10 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 38
FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD 39
FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030 39
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET 55
FIGURE 14 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022 63
FIGURE 15 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 64
FIGURE 16 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030) 64
FIGURE 17 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE 65
FIGURE 18 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022 72
FIGURE 19 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND) 73
FIGURE 20 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030) 73
FIGURE 21 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE 74
FIGURE 22 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022 80
FIGURE 23 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 81
FIGURE 24 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030) 81
FIGURE 25 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE 82
FIGURE 26 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022 87
FIGURE 27 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 88
FIGURE 28 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030) 88
FIGURE 29 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE 89
FIGURE 30 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022 98
FIGURE 31 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 99
FIGURE 32 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 99
FIGURE 33 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 100
FIGURE 34 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 105
FIGURE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 106
FIGURE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 106
FIGURE 37 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 107
FIGURE 38 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 107
FIGURE 39 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 132